Cargando…

Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú

INTRODUCTION: Acute myeloid leukemia is a heterogeneous disorder characterized by immature myeloid cell proliferation. Cytogenetic analysis has revealed the presence of chromosomal aberrations important to patient prognosis. OBJECTIVE: To determine cytogenetic risk groups of pediatric patients with...

Descripción completa

Detalles Bibliográficos
Autor principal: Llimpe, Yésica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382291/
https://www.ncbi.nlm.nih.gov/pubmed/34214271
http://dx.doi.org/10.7705/biomedica.5747
_version_ 1783741520724099072
author Llimpe, Yésica
author_facet Llimpe, Yésica
author_sort Llimpe, Yésica
collection PubMed
description INTRODUCTION: Acute myeloid leukemia is a heterogeneous disorder characterized by immature myeloid cell proliferation. Cytogenetic analysis has revealed the presence of chromosomal aberrations important to patient prognosis. OBJECTIVE: To determine cytogenetic risk groups of pediatric patients with acute myeloid leukemia according to overall survival. MATERIALS AND METHODS: In this cross-sectional observational study, the clinical records of pediatric patients diagnosed with de novo acute myeloid leukemia admitted to the Instituto Nacional de Enfermedades Neoplásicas between 2001 and 2011 with cytogenetic analysis of bone marrow were included. Cytogenetic risk groups were established according to the criteria of the Medical Research Council. Overall survival curves were generated with the Kaplan-Meier method and compared using the Mantel-Cox test and Cox regression with the software R, version 3.3.2. RESULTS: A total of 130 patients were included, 68 males (52.3%) and 62 females (47.7%), most of them with subtype M2 (33%). The average age was 7.7 years (range: 0-15 years). Chromosomal aberrations were observed in 60.8% of the patients, the most frequent of which was the translocation t(8;21). According to the overall survival analysis, two cytogenetic risk groups were established: favorable and unfavorable. CONCLUSION: Two groups of cytogenetic risk were determined: high (or unfavorable) and standard (favorable).
format Online
Article
Text
id pubmed-8382291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Instituto Nacional de Salud
record_format MEDLINE/PubMed
spelling pubmed-83822912021-08-24 Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú Llimpe, Yésica Biomedica Artículo Original INTRODUCTION: Acute myeloid leukemia is a heterogeneous disorder characterized by immature myeloid cell proliferation. Cytogenetic analysis has revealed the presence of chromosomal aberrations important to patient prognosis. OBJECTIVE: To determine cytogenetic risk groups of pediatric patients with acute myeloid leukemia according to overall survival. MATERIALS AND METHODS: In this cross-sectional observational study, the clinical records of pediatric patients diagnosed with de novo acute myeloid leukemia admitted to the Instituto Nacional de Enfermedades Neoplásicas between 2001 and 2011 with cytogenetic analysis of bone marrow were included. Cytogenetic risk groups were established according to the criteria of the Medical Research Council. Overall survival curves were generated with the Kaplan-Meier method and compared using the Mantel-Cox test and Cox regression with the software R, version 3.3.2. RESULTS: A total of 130 patients were included, 68 males (52.3%) and 62 females (47.7%), most of them with subtype M2 (33%). The average age was 7.7 years (range: 0-15 years). Chromosomal aberrations were observed in 60.8% of the patients, the most frequent of which was the translocation t(8;21). According to the overall survival analysis, two cytogenetic risk groups were established: favorable and unfavorable. CONCLUSION: Two groups of cytogenetic risk were determined: high (or unfavorable) and standard (favorable). Instituto Nacional de Salud 2021-06-15 /pmc/articles/PMC8382291/ /pubmed/34214271 http://dx.doi.org/10.7705/biomedica.5747 Text en https://creativecommons.org/licenses/by/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Artículo Original
Llimpe, Yésica
Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title_full Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title_fullStr Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title_full_unstemmed Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title_short Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
title_sort grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en perú
topic Artículo Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382291/
https://www.ncbi.nlm.nih.gov/pubmed/34214271
http://dx.doi.org/10.7705/biomedica.5747
work_keys_str_mv AT llimpeyesica gruposderiesgocitogeneticodeleucemiamieloideagudapediatricaapartirdelanalisisdesupervivenciaenunhospitaldereferenciaparacancerenperu